Trial for cancer drug rash relief withdrawn before starting
Symptom relief
Terminated
This study aimed to test the safety of an investigational product called ATR-04 for reducing the severity of a painful, acne-like facial rash that is a common side effect of certain cancer drugs. It planned to enroll about 60 adults with cancer who were starting these specific dr…
Phase: PHASE1, PHASE2 • Sponsor: Azitra Inc. • Aim: Symptom relief
Last updated Mar 25, 2026 14:08 UTC